Evidence-based·Updated November 20, 2026·How we grade evidence

Sirolimus (Rapamycin)

MedicationImmunosuppressant (prescription)

Sirolimus is an mTOR-blocking immunosuppressant. Large randomized trials showed that adding it to cyclosporine and steroids cut acute kidney transplant rejection, and a randomized trial in LAM showed it stabilized lung function while it was taken. It has boxed warnings for infection and cancer risk and is not recommended after liver or lung transplant. Grapefruit and live probiotic supplements are the high-severity food and supplement concerns.

Taking Sirolimus (Rapamycin) with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Kidney transplant recipients aged 13 or older, and adults with lymphangioleiomyomatosis, whose specialist prescribes sirolimus

Common dosing range

Set by your transplant team or lung specialist and adjusted to blood levels: for example a 6 mg loading dose then 2 mg once daily after a kidney transplant at low to moderate risk, or 2 mg a day to start for LAM

When to expect effects

Blood levels take days to settle because of the long half-life; in the LAM trial, lung function was measured over 12 months

Watch out for

Boxed warnings: higher risk of infection, lymphoma and other cancers; not recommended in liver or lung transplant patients. Avoid grapefruit. Many drugs and some supplements change its blood levels

What is it

Sirolimus (also called rapamycin) is a prescription immunosuppressant taken by mouth as tablets or an oral solution. Its label approves it to prevent organ rejection in people 13 years or older who receive a kidney transplant, used at first together with cyclosporine and corticosteroids, and to treat lymphangioleiomyomatosis (LAM), a rare, slowly progressive lung disease that mostly affects women. Only doctors experienced in immunosuppressive therapy should prescribe it for transplant patients, and its dose is guided by blood-level tests. This page is about the tablets and oral solution, not the sirolimus skin gel or the sirolimus injection, which are separate products with their own labels.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have had a kidney transplant and your transplant team includes sirolimus in your anti-rejection regimen
You have lymphangioleiomyomatosis and your lung specialist recommends sirolimus
You can keep regular blood-level tests and take each dose the same way every day, always with food or always without
You are willing to check every supplement, food habit and new medicine with your transplant team or pharmacist

Probably skip if…

You are allergic to sirolimus (contraindicated)
You have had a liver or lung transplant, where the label says use is not recommended
You cannot avoid grapefruit or grapefruit juice
You take a strong CYP3A4 or P-gp blocker or inducer the label says to avoid, without your prescriber's review

Evidence at a glance

preventing acute rejection after kidney transplant

Good Evidence
Effect
Moderate; biopsy-confirmed acute rejection in the first 6 months fell by about 40% to 60% versus azathioprine or placebo
Best fit
Adults receiving a first kidney transplant, treated together with cyclosporine and corticosteroids
Time
Measured over the first 6 and 12 months after transplant

kidney function after stopping cyclosporine

Good Evidence
Effect
Small to moderate gain in kidney function, with more acute rejection
Best fit
Kidney transplant recipients at low to moderate immunologic risk
Time
Measured 12 months after transplant

lymphangioleiomyomatosis (LAM)

Good Evidence
Effect
Moderate; lung function stabilized instead of declining, only while the drug was taken
Best fit
Adults with LAM and moderate lung impairment
Time
Measured over 12 months of treatment

Evidence for 3 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

preventing acute rejection after kidney transplant

Disease adjunct
Good Evidence

Two double-blind randomized trials tested sirolimus added to cyclosporine and steroids in first kidney transplant recipients. In 719 patients, the 6-month rate of efficacy failure (biopsy-confirmed acute rejection, graft loss or death) was 18.7% with sirolimus 2 mg a day and 16.8% with 5 mg, versus 32.3% with azathioprine; biopsy-confirmed acute rejection was 16.9% and 12.0% versus 29.8%. In 576 patients, the same composite outcome occurred in 30.0% (2 mg) and 25.6% (5 mg) versus 47.7% on placebo. In the first trial, graft survival (97.2%, 96.0% and 98.1%) and patient survival at 12 months were similar across groups.

Effect size
Moderate; biopsy-confirmed acute rejection in the first 6 months fell by about 40% to 60% versus azathioprine or placebo
Time to effect
Measured over the first 6 and 12 months after transplant
Best fit
Adults receiving a first kidney transplant, treated together with cyclosporine and corticosteroids
Less likely
Liver and lung transplant recipients, in whom use is not recommended, and children under 13

Bottom line: Adding sirolimus to cyclosporine and steroids lowered early kidney transplant rejection; 1-year graft and patient survival were similar to azathioprine.

kidney function after stopping cyclosporine

Disease adjunct
Good Evidence

In an open-label randomized trial of 430 kidney transplant recipients, patients on sirolimus, cyclosporine and steroids were randomized at 3 months to keep cyclosporine or to stop it and continue sirolimus at higher blood levels. At 12 months, graft survival (95.8% vs 97.2%) and patient survival were similar. Kidney function was better (calculated filtration rate 63 vs 57 mL/min) and blood pressure lower after cyclosporine was withdrawn, but acute rejection after randomization was higher (9.8% vs 4.2%).

Effect size
Small to moderate gain in kidney function, with more acute rejection
Time to effect
Measured 12 months after transplant
Best fit
Kidney transplant recipients at low to moderate immunologic risk
Less likely
People at high immunologic risk, Black recipients and others the label says were not studied for cyclosporine withdrawal

Bottom line: Stopping cyclosporine and continuing sirolimus improved kidney function at a cost of more rejection episodes.

lymphangioleiomyomatosis (LAM)

Disease adjunct
Good Evidence

In the double-blind MILES trial, 89 patients with LAM and moderate lung impairment took sirolimus or placebo for 12 months. Lung function (FEV1) fell by 12 mL per month on placebo and rose by 1 mL per month on sirolimus; the between-group difference in mean FEV1 change was 153 mL, about 11% of the starting value. Quality of life also improved, but 6-minute walk distance and gas transfer did not differ. After sirolimus was stopped, lung function decline resumed at the placebo rate. Adverse events were more common on sirolimus, while serious adverse events did not differ significantly.

Effect size
Moderate; lung function stabilized instead of declining, only while the drug was taken
Time to effect
Measured over 12 months of treatment
Best fit
Adults with LAM and moderate lung impairment
Less likely
People expecting a lasting effect after stopping, since decline resumed off the drug

Bottom line: Sirolimus stabilized lung function in LAM for as long as it was taken.

How it works

Sirolimus binds a protein inside immune cells and blocks mTOR (mammalian target of rapamycin), an enzyme that cells need to grow and divide. In T cells and B cells this stops the activation and multiplication that drive transplant rejection. In LAM, abnormal lung cells have an overactive mTOR pathway, and sirolimus slows their growth. Its half-life is long, about 62 hours in stable kidney transplant patients, so the label says a new dose needs at least 7 to 14 days before it is adjusted again. Sirolimus is broken down by the liver and gut enzyme CYP3A4 and pumped by the P-gp transporter, and it has a narrow range between too little (rejection) and too much (toxicity). Anything that blocks these pathways, such as grapefruit juice, raises blood levels; anything that speeds them up lowers them. The label also lists St. John's wort as able to lower sirolimus levels and says cannabidiol (CBD) may raise them. Because the drug suppresses the immune system, live probiotic supplements are a concern for some people taking it.

How to take it

1. Typical dose
Your prescriber sets the dose and adjusts it to your blood levels. The label lists: kidney transplant at low to moderate immunologic risk, a loading dose 3 times the maintenance dose (for example 6 mg, then 2 mg once daily) with cyclosporine and corticosteroids, then cyclosporine is tapered off 2 to 4 months after transplant and the sirolimus dose is raised to reach the target blood level; kidney transplant at high immunologic risk, up to 15 mg on day 1 then 5 mg a day to start; lymphangioleiomyomatosis, 2 mg a day to start, with blood levels kept between 5 and 15 ng/mL. Doses are lower in people under 40 kg and in liver impairment.
2. Higher studied dose
The label says no more than 40 mg should be given on any one day; if a loading dose would exceed this, it is split over 2 days.
3. Timing
Once a day. If you also take cyclosporine (modified), the label recommends taking sirolimus 4 hours after the cyclosporine dose.
4. With food
Take it consistently either with food or without food, the same way each time, because a high-fat meal raised sirolimus exposure by 23 to 35%. Tablets should not be crushed, chewed or split. The oral solution is mixed only in water or orange juice (at least 60 mL), never grapefruit juice.
5. Split dosing
Not split; sirolimus is taken once daily.
6. How long to try
Long term, as decided by your transplant team or lung specialist. In the LAM trial, lung function decline came back after sirolimus was stopped. Do not stop or change the dose on your own.

What to track

Sirolimus trough blood levels, which the label says should be checked at least every 3 months once the dose is stable, and after any dose, dosage-form or interacting-drug change
Fever, chills, cough or other signs of infection (report them promptly)
Cholesterol and triglycerides, kidney function and urine protein, as your team schedules them
New skin spots or changes; limit sun exposure and use protective clothing and a high-protection broad-spectrum sunscreen
Swelling of the face, lips or tongue, new shortness of breath or cough, slow wound healing
Every new medicine, supplement or herbal product, including CBD and St. John's wort

Bottom line: Your prescriber sets and adjusts the dose by blood level; take it once daily the same way with respect to food, never with grapefruit, and check every supplement first.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

After kidney transplant (30% or more): swelling of the legs, high triglycerides and cholesterol, high blood pressure, raised creatinine, belly pain, diarrhea, headache, fever, urinary tract infection, anemia, nausea, joint pain and low plateletsIn LAM (20% or more): mouth sores, diarrhea, belly pain, nausea, colds, acne, chest pain, leg swelling, headache, dizziness and muscle painSlow or poor wound healing and fluid buildupHigh cholesterol and triglycerides that often need treatment

Serious risks

  • Boxed warning: higher risk of infection and possible lymphoma and other cancers, particularly of the skin, from immunosuppression. Over-suppression can lead to opportunistic infections such as tuberculosis, sepsis and fatal infections. Only physicians experienced in immunosuppressive therapy should manage it.

  • Boxed warning: not recommended after liver transplant. With tacrolimus it was linked to excess deaths and graft loss (22% vs 9%), and with cyclosporine or tacrolimus to more hepatic artery thrombosis (7% vs 2%), most cases leading to graft loss or death.

  • Boxed warning: not recommended after lung transplant. Cases of bronchial anastomotic dehiscence (breakdown of the airway connection), most fatal, have been reported.

  • Allergic reactions including anaphylaxis and angioedema (risk may rise with ACE inhibitors), lung inflammation not caused by infection (interstitial lung disease, some fatal), declining kidney function with cyclosporine, protein in the urine, reactivation of latent viruses such as BK virus, and progressive multifocal leukoencephalopathy (PML).

  • Vaccines: the label says live vaccines (for example measles, mumps, rubella, oral polio, yellow fever, varicella, BCG and oral typhoid) should be avoided during treatment, and that other vaccines may work less well. Ask your transplant team which vaccines you need and when.

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the label says that, based on animal studies and how it works, sirolimus can cause fetal harm, and that limited human data are not enough to define the risk. Females who could become pregnant are advised to use highly effective contraception before, during and for 12 weeks after stopping sirolimus. The label also says it may impair male and female fertility. Breastfeeding: the label says it is not known whether sirolimus passes into human milk, there are no data on effects on the breastfed infant or milk production, it is present in rat milk, and there is potential for serious adverse effects in breastfed infants; the benefits of breastfeeding should be weighed against the mother's need for the drug.

Interactions

Grapefruit and grapefruit juiceHigh

Grapefruit juice blocks CYP3A4, the enzyme that breaks down sirolimus, so blood levels can rise unpredictably. The label says grapefruit juice must not be taken with sirolimus or used to dilute the oral solution, which is mixed only in water or orange juice. If you have had grapefruit, tell your transplant team, who may check a blood level.

Probiotics (live bacteria or yeast supplements)High

In people whose immune system is suppressed, live probiotic organisms can occasionally get into the blood. In a cluster of 6 children after stem cell transplant, the Lactobacillus found in their blood was genetically related to the probiotic they had taken; the report was not a study of sirolimus, and the authors said studies are needed on probiotic safety in immunocompromised patients. Ask your transplant or lung team before taking any probiotic supplement, and report fever or chills promptly.

Ketoconazole, voriconazole, itraconazole, clarithromycin, erythromycin and other strong CYP3A4 or P-gp blockersHigh

The label says to avoid sirolimus with strong CYP3A4 or P-gp blockers, which raise its blood levels, and to consider alternatives with less interaction potential. Weaker blockers such as diltiazem, verapamil, fluconazole and some HIV and hepatitis C drugs also raise levels and may need dose changes. Make sure every prescriber knows you take sirolimus.

Rifampin, rifabutin and other strong CYP3A4 or P-gp inducersHigh

The label says to avoid these, because they lower sirolimus levels and could leave you under-protected against rejection. Carbamazepine, phenobarbital, phenytoin and rifapentine can also lower levels. Ask your prescriber before starting any of them.

St. John's wort (Hypericum perforatum)High

St. John's wort induces CYP3A4 and P-glycoprotein, the enzyme and transporter that clear sirolimus, and the label says there is the potential that it could reduce sirolimus concentrations; it lists the herb among agents that could decrease sirolimus levels. Lower levels can weaken protection against rejection. No study has measured this pair in people. Ask your transplant team before using it in any form, including teas and mood or sleep blends.

CBD (cannabidiol, including Epidiolex)High

The label says sirolimus blood levels may increase with cannabidiol and asks prescribers to monitor levels closely and consider a lower sirolimus dose. In a records review of 25 patients with tuberous sclerosis complex taking cannabidiol as a seizure medicine, sirolimus or everolimus trough levels were higher in 76% after cannabidiol was added, with a median rise of 5.1 ng/mL for sirolimus. Over-the-counter CBD amounts have not been studied. Tell your transplant team before starting or stopping any CBD product.

CyclosporineModerate

Cyclosporine raises sirolimus levels. The label recommends taking sirolimus 4 hours after cyclosporine (modified), and says higher sirolimus doses are needed when cyclosporine is withdrawn. The combination can also lower kidney function over time, so kidney tests are watched closely. Your transplant team manages both doses.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic sirolimus tablets (0.5, 1 or 2 mg) or oral solution (1 mg/mL) dispensed on your own prescription
Instructions to take it the same way every day with respect to food, and never with grapefruit juice
For the oral solution, the dosing syringe and instructions to mix it only in water or orange juice
Your pharmacy's interaction check, especially for antifungals, antibiotics and seizure medicines

Be skeptical of…

Sirolimus or "rapamycin" sold or promoted online for anti-aging or longevity; these are not approved uses, and the label carries infection and cancer warnings
"Immune-boosting" supplements presented as safe with transplant medicines
Probiotic products marketed as safe for transplant recipients without your team's approval
Any seller offering sirolimus without a prescription and blood-level monitoring

Frequently asked questions

Can I eat grapefruit while taking sirolimus?⌄

No. The label says grapefruit juice must not be taken with sirolimus or used to mix the oral solution, because it blocks the enzyme that breaks sirolimus down and can raise blood levels unpredictably. This page rates it a high-severity interaction. If you have had grapefruit, tell your transplant team.

Can I take probiotics with sirolimus?⌄

This page rates live probiotic supplements a high-severity concern for anyone on immunosuppressants. The evidence is limited: one report describes 6 children after stem cell transplant whose bloodstream Lactobacillus was genetically related to the probiotic they had taken, and it was not a study of sirolimus. Ask your transplant or lung team before taking any probiotic.

Does St. John's wort or CBD affect sirolimus?⌄

The sirolimus label says St. John's wort could lower sirolimus levels, because it speeds up the enzyme and pump that clear sirolimus. It also says CBD (cannabidiol) may raise sirolimus levels, and that blood levels and side effects should be watched closely when the two are used together. Ask your prescriber or pharmacist before using either.

Should I take sirolimus with or without food?⌄

Either, but the same way every time. A high-fat meal raised sirolimus exposure by 23 to 35%, so switching back and forth makes blood levels harder to control. Your team adjusts the dose to your blood levels.

Is sirolimus the same as the rapamycin people take for longevity?⌄

It is the same molecule, but its approved uses are preventing kidney transplant rejection and treating LAM. Anti-aging use is not an approved use, and the label carries boxed warnings for infection and cancer risk. Talk to your doctor before considering any use outside a prescription.

Can I get vaccines while taking sirolimus?⌄

The label says to avoid live vaccines, such as measles, mumps, rubella, yellow fever, varicella and oral typhoid, and that other vaccines may work less well. Ask your transplant team which vaccines you need and when.

References by claim

preventing acute rejection after kidney transplant

Kahan et al., 2000 · PubMed (2000) link

MacDonald et al., 2001 · PubMed (2001) link

kidney function after stopping cyclosporine

Johnson et al., 2001 · PubMed (2001) link

lymphangioleiomyomatosis (LAM)

McCormack et al., 2011 · PMC (2011) link

Safety

Sirolimus tablets prescribing information · DailyMed (FDA label) link

Interaction: Grapefruit and grapefruit juice

Sirolimus oral solution prescribing information · DailyMed (FDA label) link

Interaction: Probiotics (live bacteria or yeast supplements)

Gilliam et al., 2023 · PubMed (2023) link

Interaction: CBD (cannabidiol, including Epidiolex)

Ebrahimi-Fakhari et al., 2020 · PubMed (2020) link

Track Sirolimus (Rapamycin) with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.